Soteri Skin Active Flare-up Eczema Relief Cream

Dosage for Oatmeal allergenic extract is highly individualized and must be performed by an allergy specialist.

• Skin Prick Testing: Typically, one drop of a 1:10 or 1:20 w/v concentration is applied to the skin, followed by a puncture with a sterile lancet.
• Intradermal Testing: If the prick test is negative, a clinician may inject 0.02 mL of a much more dilute solution (e.g., 1:1000 w/v) into the skin.

Pediatric dosing for skin testing is generally the same as adult dosing regarding the concentration of the extract; however, the number of tests performed in a single session may be limited by the child's size and tolerance. Safety and efficacy for immunotherapy in children under age 5 have not been extensively established.

Renal Impairment

No dosage adjustment is typically required for diagnostic testing due to minimal systemic absorption.

Hepatic Impairment

No dosage adjustment is typically required.

Elderly Patients

Elderly patients may have reduced skin reactivity; clinicians may need to interpret results with caution, but the dose remains standard.

Oatmeal extract is never for self-administration. It must be administered in a clinical setting equipped with emergency resuscitation equipment.

• Storage: Must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Preparation: The vial should be inspected for particulate matter or discoloration before use.

In the context of diagnostic testing, a missed appointment should be rescheduled. For immunotherapy, a missed dose may require a 'step-back' in dosage to maintain safety; consult your allergist immediately.

An overdose of allergenic extract can lead to a systemic allergic reaction or anaphylaxis. Symptoms include generalized hives, swelling of the throat, wheezing, and low blood pressure. Emergency treatment with epinephrine is required.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt self-testing without medical guidance.

• Local Wheal and Flare: This is the intended diagnostic response. It involves a raised, itchy bump (wheal) and surrounding redness (flare) at the test site. It usually peaks within 15–20 minutes and resolves within a few hours.
• Local Itching: Significant pruritus (itching) at the site of administration.

• Delayed Local Reaction: Swelling or redness that appears 6 to 24 hours after the test.
• Large Local Reactions: Swelling that extends significantly beyond the initial test site.

• Generalized Urticaria: Hives appearing on parts of the body far from the test site.
• Angioedema: Swelling of the deeper layers of the skin, often around the eyes or lips.

> Warning: Stop the procedure and call for emergency help if you experience any of these symptoms of anaphylaxis:

• Difficulty Breathing: Wheezing or a feeling of tightness in the chest.
• Throat Swelling: Feeling like your throat is closing or difficulty swallowing.
• Dizziness or Fainting: A sudden drop in blood pressure (hypotension).
• Rapid Pulse: A racing heartbeat accompanied by a sense of impending doom.

There are no known long-term side effects associated with diagnostic use of Oatmeal extract. Repeated use in immunotherapy carries a persistent risk of systemic reactions during the course of treatment.

While not all Oatmeal extracts carry a specific boxed warning, many allergenic extracts carry a general warning regarding the risk of Severe Systemic Allergic Reactions. This includes the risk of anaphylaxis, which can be fatal. Administration must occur in a facility prepared to treat such reactions.

Report any unusual symptoms to your healthcare provider immediately.

Oatmeal allergenic extract should only be administered by physicians experienced in the diagnosis and treatment of allergic diseases. Patients should be observed for at least 30 minutes following administration to monitor for systemic reactions.

No specific FDA black box warning exists uniquely for Oatmeal extract; however, it falls under the general class warning for allergenic extracts: Risk of Anaphylaxis. This product can cause severe, life-threatening systemic reactions. It must be administered in a setting where emergency medications (like epinephrine) and resuscitation equipment are immediately available.

• Allergic Reactions / Anaphylaxis Risk: Patients with high sensitivity or those undergoing testing during peak allergy seasons may be at higher risk.
• Asthma: Patients with unstable or severe asthma are at a significantly higher risk for severe systemic reactions if an extract is administered.
• Beta-Blocker Use: Patients taking beta-blockers may be resistant to the effects of epinephrine if an emergency occurs.

• Observation: 30-minute post-administration clinical observation.
• Skin Site Assessment: Measurement of wheal and flare diameter.
• Respiratory Status: Monitoring for wheezing or respiratory distress in high-risk patients.

Oatmeal extract generally does not affect the ability to drive; however, if a systemic reaction occurs or if antihistamines are administered to treat a reaction, these may cause drowsiness.

Alcohol may increase blood flow to the skin and potentially exacerbate a local or systemic reaction. It is generally advised to avoid alcohol for 24 hours before and after testing.

Testing is a one-time event. If undergoing immunotherapy, discontinuation should be managed by an allergist to avoid loss of desensitization.

> Important: Discuss all your medical conditions, especially asthma and heart conditions, with your healthcare provider before starting Oatmeal extract testing.

• Beta-Blockers (e.g., Propranolol, Atenolol): These medications can make a systemic allergic reaction more difficult to treat by blocking the effects of epinephrine. Using Oatmeal extract while on beta-blockers requires a careful risk-benefit analysis by a physician.

• ACE Inhibitors: May increase the risk or severity of systemic reactions in some patients.
• MAO Inhibitors: May potentiate the effects of sympathomimetics used to treat a potential reaction.

• Antihistamines (e.g., Loratadine, Cetirizine): These drugs will suppress the 'wheal and flare' response, leading to a false-negative test result. They must be discontinued 3 to 7 days prior to testing.
• H2 Blockers (e.g., Famotidine): May also partially suppress skin reactivity.
• Topical Corticosteroids: Applied to the test site, these can suppress the local inflammatory response.

There are no direct food interactions that change the metabolism of the extract, but patients should avoid consuming oats immediately before a diagnostic test to prevent confounding symptoms.

• St. John's Wort: May theoretically interact with emergency medications if a reaction occurs.
• High-dose Vitamin C: Some studies suggest it may have mild antihistamine properties that could dampen skin test results.

Oatmeal extract testing is itself a diagnostic procedure. It does not typically interfere with standard blood chemistries, but it will interfere with other skin tests if performed too closely together in the same area.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any allergy medications or heart pills.

• Severe Hypersensitivity: Patients who have previously had a life-threatening anaphylactic reaction to very small amounts of oat protein.
• Unstable Asthma: Patients with significantly compromised lung function (FEV1 <70% of predicted) are at extreme risk during testing.
• Acute Infection: Testing should not be performed during an active febrile illness.

• Pregnancy: While not strictly contraindicated, testing is often deferred until postpartum to avoid the risk of anaphylaxis-induced fetal hypoxia.
• Severe Eczema/Dermatitis: If the skin at the test site is inflamed or diseased, the results will be uninterpretable.

Patients allergic to Oatmeal may also show sensitivity to other cereal grains such as wheat, barley, or rye due to similar protein structures (prolamins). This is known as cross-reactivity.

> Important: Your healthcare provider will evaluate your complete medical history and current respiratory health before prescribing Oatmeal extract testing.

Oatmeal extract is classified as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Testing is generally avoided during pregnancy because a systemic reaction (anaphylaxis) could cause uterine contractions or fetal hypoxia (lack of oxygen).

It is unknown if the components of Oatmeal extract pass into breast milk. Because systemic absorption is minimal during skin testing, it is generally considered low risk, but clinicians should weigh the benefits against potential risks.

Oatmeal extract is used in children for allergy diagnosis. However, very young children (infants) may have less reactive skin, leading to potential false negatives. The psychological stress of skin testing in children must also be managed.

Patients over 65 may have thinner skin and reduced IgE reactivity. This can lead to smaller wheal sizes. Additionally, older patients are more likely to be on medications (like beta-blockers) that increase the risk of complications from testing.

No specific studies have been conducted in patients with renal impairment. However, given the local nature of the diagnostic test, no dose adjustments are typically required.

No dose adjustments are required for patients with liver disease.

> Important: Special populations require individualized medical assessment by an allergy specialist.

Oatmeal extract contains various proteins, including avenins, which act as allergens. In a sensitized individual, these proteins cross-link IgE antibodies bound to high-affinity receptors (FcεRI) on mast cells and basophils. This cross-linking triggers a signal transduction cascade resulting in degranulation and the release of pre-formed mediators like histamine, leukotrienes, and cytokines.

The primary pharmacodynamic effect is the induction of a localized inflammatory response. The onset of the wheal (swelling) and flare (redness) occurs within 5 minutes, peaks at 15–20 minutes, and usually subsides within 1 to 2 hours. The size of the wheal is generally proportional to the degree of the patient's sensitivity.

| Parameter | Value |

|---|---|

| Bioavailability | Minimal (Epicutaneous) |

| Protein Binding | N/A (Local interaction) |

| Half-life | Not established for extracts |

| Tmax | 15–20 minutes (Local reaction) |

| Metabolism | Local proteolytic degradation |

| Excretion | Lymphatic clearance |

Oatmeal extract is a complex mixture of proteins, carbohydrates, and lipids extracted from Avena sativa. It is not a single molecular entity. The primary allergenic components are the globulin and prolamine (avenin) protein fractions.

Oatmeal is classified as a Non-Standardized Food Allergenic Extract. It is related to other grain extracts such as Wheat, Barley, and Rye extracts used in allergy diagnostics.